ABCG2 and cancer: Our findings indicate that bacopaside II exerts anti-cancer effects on TNBC cells and improves doxorubicin efficacy, mainly by increasing intracellular drug accumulation and potentially inhibiting ABC transporter-mediated drug efflux.